Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Providing the solutions you need, when you need them, to increase productivity.
Available on-demand
The vaccine and biotherapeutic manufacturing industries are under pressure to address critical challenges of speed, scale, and supply in its response to SARS-CoV-2. What does this mean for technologies enabling production and how does this impact the future of vaccine and biotherapeutic manufacturing?
During this on-demand webinar, our panel of experts provide insights on challenges facing the industry and how they impact success.
This webinar will provide you with an essential toolkit to help you make the right decision when choosing to outsource your cell culture media.
How can outsourcing buffer preparation help meet the world’s urgent need for a SARS-CoV-2 vaccine?
This webinar provides an industry overview from a leading provider of RNA technology products and discusses products available for the manufacture of mRNA.
This whitepaper examines the need for highly scalable mRNA production, and then explores the affinity resin’s advantages over other mRNA purification techniques.
Improve mRNA purification process efficiency.
Standard methods of preparing mRNA require multiple purification steps. Learn more about the simple adoption process for upscaling your mRNA purification process using the Oligo (dT)25 Affinity Resin.
Part of our BioProduction Division, is helping our customers in their fight against SARS-CoV-2 by providing assurance of supply. This video discusses our escalation routes through the Coronavirus Command Centre, our SUT capacity expansions and contains a customer testimonial from AGC Biologics.
To meet the increased demand and quality expectations, we've expanded the Single-use technologies manufacturing network.
This webinar provides an industry overview from a leading provider of RNA technology products and discuss products available for the manufacture of mRNA.
Learn how to benefit from recent technological advances to develop or improve your vaccine’s downstream bioprocess, either microbial or animal cells based.
Learn how to benefit from recent technological advances to develop or improve your vaccine’s upstream bioprocess, either microbial or animal cells based.
Watch this educational webinar and learn how recent innovation can help you to significantly push the boundaries of viral vectors productivity and quality. Discover how recent innovation in areas such as cells, media and transfection agents can boost and standardise your process, as illustrated by our lentiviral case study.
Innovation in quality, ease of use and providing the highest process security.
Due to the growing diversity of vaccines, tailored purifications solutions are needed more than ever and are designed for both analytical and process-scale separations of biomolecules.
Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing: